Pharmacyclics CLL drug, Imbruvica gets FDA approval

PRESS RELEASE The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia (CLL) patients who have received at least one previous therapy. CLL is More...